{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:48:37Z","timestamp":1790707717071,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K10705"],"award-info":[{"award-number":["16K10705"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00262-023-03431-5","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T10:02:01Z","timestamp":1681552921000},"page":"2585-2596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression"],"prefix":"10.1007","volume":"72","author":[{"given":"Tatsuo","family":"Furuya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunta","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saya","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Nakazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Tando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yaoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4718-7098","authenticated-orcid":false,"given":"Masayoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,15]]},"reference":[{"key":"3431_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jtho.2021.10.010","volume":"17","author":"A Marx","year":"2022","unstructured":"Marx A, Chan JKC, Chalabreysse L et al (2022) The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors? J Thorac Oncol 17:200\u2013213","journal-title":"J Thorac Oncol"},{"key":"3431_CR2","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","volume":"76","author":"K Kondo","year":"2003","unstructured":"Kondo K, Monden Y (2003) Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76:878\u2013884","journal-title":"Ann Thorac Surg"},{"key":"3431_CR3","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jtho.2022.08.007","volume":"17","author":"CB Falkson","year":"2022","unstructured":"Falkson CB, Vella ET, Ellis PM et al (2022) Surgical, radiation, and systemic treatments of patients with thymic epithelial tumours: a clinical practice guideline. J Thorac Oncol 17:1258\u20131275","journal-title":"J Thorac Oncol"},{"key":"3431_CR4","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1200\/JCO.2017.77.3184","volume":"37","author":"J Cho","year":"2019","unstructured":"Cho J, Kim HS, Ku BM et al (2019) Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial. J Clin Oncol 37:2162\u20132170","journal-title":"J Clin Oncol"},{"key":"3431_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1470-2045(18)30062-7","volume":"19","author":"G Giaccone","year":"2018","unstructured":"Giaccone G, Kim C, Thompson J et al (2018) Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. Lancet Oncol 19:347\u2013355","journal-title":"Lancet Oncol"},{"key":"3431_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/intimm\/dxm057","volume":"19","author":"T Okazaki","year":"2007","unstructured":"Okazaki T, Honjo T (2007) PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 19:813\u2013824","journal-title":"Int Immunol"},{"key":"3431_CR7","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1158\/0008-5472.CAN-16-3167","volume":"77","author":"BA Kansy","year":"2017","unstructured":"Kansy BA, Concha-Benavente F, Srivastava RM et al (2017) PD-1 status in CD8 T cells associates with survival and anti-PD-1 therapeutic outcomes in head and neck cancer. Cancer Res 77:6353\u20136364","journal-title":"Cancer Res"},{"key":"3431_CR8","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1172\/JCI73639","volume":"124","author":"A Gros","year":"2014","unstructured":"Gros A, Robbins PF, Yao X et al (2014) PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors. J Clin Invest 124:2246\u20132259","journal-title":"J Clin Invest"},{"key":"3431_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","volume":"8","author":"Y Agata","year":"1996","unstructured":"Agata Y, Kawasaki A, Nishimura H et al (1996) Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 8:765\u2013772","journal-title":"Int Immunol"},{"key":"3431_CR10","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","volume":"11","author":"Y Ishida","year":"1992","unstructured":"Ishida Y, Agata Y, Shibahara K et al (1992) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11:3887\u20133895","journal-title":"EMBO J"},{"key":"3431_CR11","doi-asserted-by":"publisher","first-page":"7372","DOI":"10.4049\/jimmunol.175.11.7372","volume":"175","author":"ME Keir","year":"2005","unstructured":"Keir ME, Latchman YE, Freeman GJ et al (2005) Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes. J Immunol 175:7372\u20137379","journal-title":"J Immunol"},{"key":"3431_CR12","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.4049\/jimmunol.171.9.4574","volume":"171","author":"C Blank","year":"2003","unstructured":"Blank C, Brown I, Marks R et al (2003) Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4\/CD8 double-negative TCR-transgenic T cells. J Immunol 171:4574\u20134581","journal-title":"J Immunol"},{"key":"3431_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nri1257","volume":"4","author":"JC Z\u00fa\u00f1iga-Pfl\u00fccker","year":"2004","unstructured":"Z\u00fa\u00f1iga-Pfl\u00fccker JC (2004) T-cell development made simple. Nat Rev Immunol 4:67\u201372","journal-title":"Nat Rev Immunol"},{"key":"3431_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jaci.2015.08.022","volume":"137","author":"AS Wiekmeijer","year":"2016","unstructured":"Wiekmeijer AS, Pike-Overzet K, IJspeert H et al (2016) Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells. J Allergy Clin Immunol 137:517\u201326.e3","journal-title":"J Allergy Clin Immunol"},{"key":"3431_CR15","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.4049\/jimmunol.162.7.3978","volume":"162","author":"KJ Hare","year":"1999","unstructured":"Hare KJ, Jenkinson EJ, Anderson G (1999) CD69 expression discriminates MHC-dependent and -independent stages of thymocyte positive selection. J Immunol 162:3978\u20133983","journal-title":"J Immunol"},{"key":"3431_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/eji.1830230326","volume":"23","author":"W Swat","year":"1993","unstructured":"Swat W, Dessing M, von Boehmer H et al (1993) CD 69 expression during selection and maturation of CD4+8+ thymocytes. Eur J Immunol 23:739\u2013746","journal-title":"Eur J Immunol"},{"key":"3431_CR17","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1073\/pnas.96.4.1536","volume":"96","author":"FK Kong","year":"1999","unstructured":"Kong FK, Chen CL, Six A et al (1999) T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool. Proc Natl Acad Sci U S A 96:1536\u20131540","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3431_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/cdd.2009.206","volume":"17","author":"SP Cullen","year":"2010","unstructured":"Cullen SP, Brunet M, Martin SJ (2010) Granzymes in cancer and immunity. Cell Death Differ 17:616\u2013623","journal-title":"Cell Death Differ"},{"key":"3431_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","volume":"20","author":"JH Russell","year":"2002","unstructured":"Russell JH, Ley TJ (2002) Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20:323\u2013370","journal-title":"Annu Rev Immunol"},{"key":"3431_CR20","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","volume":"184","author":"C Cui","year":"2021","unstructured":"Cui C, Wang J, Fagerberg E et al (2021) Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell 184:6101\u201318.e13","journal-title":"Cell"},{"key":"3431_CR21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ (2011) T cell exhaustion. Nat Immunol 12:492\u2013499","journal-title":"Nat Immunol"},{"key":"3431_CR22","doi-asserted-by":"publisher","first-page":"7875","DOI":"10.1073\/pnas.1003345107","volume":"107","author":"J Matsuzaki","year":"2010","unstructured":"Matsuzaki J, Gnjatic S, Mhawech-Fauceglia P et al (2010) Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc Natl Acad Sci U S A 107:7875\u20137880","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3431_CR23","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.4049\/jimmunol.0804211","volume":"182","author":"JF Grosso","year":"2009","unstructured":"Grosso JF, Goldberg MV, Getnet D et al (2009) Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells. J Immunol 182:6659\u20136669","journal-title":"J Immunol"},{"key":"3431_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2014.00019","volume":"5","author":"M Sawicka","year":"2014","unstructured":"Sawicka M, Stritesky GL, Reynolds J et al (2014) From pre-DP, post-DP, SP4, and SP8 thymocyte cell counts to a dynamical model of cortical and medullary selection. Front Immunol 5:19","journal-title":"Front Immunol"},{"key":"3431_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nri3667","volume":"14","author":"L Klein","year":"2014","unstructured":"Klein L, Kyewski B, Allen PM et al (2014) Positive and negative selection of the T cell repertoire: what thymocytes see (and don\u2019t see). Nat Rev Immunol 14:377\u2013391","journal-title":"Nat Rev Immunol"},{"key":"3431_CR26","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jtho.2018.04.013","volume":"13","author":"D Owen","year":"2018","unstructured":"Owen D, Chu B, Lehman AM et al (2018) Expression patterns, prognostic value, and intratumoral heterogeneity of PD-L1 and PD-1 in thymoma and thymic carcinoma. J Thorac Oncol 13:1204\u20131212","journal-title":"J Thorac Oncol"},{"key":"3431_CR27","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1038\/s41598-020-61053-8","volume":"10","author":"Y Yamamoto","year":"2020","unstructured":"Yamamoto Y, Iwahori K, Funaki S et al (2020) Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors. Sci Rep 10:4064","journal-title":"Sci Rep"},{"key":"3431_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.celrep.2017.03.037","volume":"19","author":"T Tsujikawa","year":"2017","unstructured":"Tsujikawa T, Kumar S, Borkar RN et al (2017) Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis. Cell Rep 19:203\u2013217","journal-title":"Cell Rep"},{"key":"3431_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.lungcan.2020.04.038","volume":"145","author":"S Ishihara","year":"2020","unstructured":"Ishihara S, Okada S, Ogi H et al (2020) Programmed death-ligand 1 expression profiling in thymic epithelial cell tumors: clinicopathological features and quantitative digital image analyses. Lung Cancer 145:40\u201347","journal-title":"Lung Cancer"},{"key":"3431_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.lungcan.2015.03.003","volume":"88","author":"Y Katsuya","year":"2015","unstructured":"Katsuya Y, Fujita Y, Horinouchi H et al (2015) Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma. Lung Cancer 88:154\u2013159","journal-title":"Lung Cancer"},{"key":"3431_CR31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/modpathol.2017.6","volume":"30","author":"A Weissferdt","year":"2017","unstructured":"Weissferdt A, Fujimoto J, Kalhor N et al (2017) Expression of PD-1 and PD-L1 in thymic epithelial neoplasms. Mod Pathol 30:826\u2013833","journal-title":"Mod Pathol"},{"key":"3431_CR32","first-page":"419","volume":"12","author":"M Inoue","year":"1998","unstructured":"Inoue M, Fujii Y, Okumura M et al (1998) Neoplastic thymic epithelial cells of human thymoma support T cell development from CD4-CD8- cells to CD4+CD8+ cells in vitro. Clin Exp Immunol 12:419\u2013426","journal-title":"Clin Exp Immunol"},{"key":"3431_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00281-021-00842-3","volume":"43","author":"A Marx","year":"2021","unstructured":"Marx A, Yamada Y, Simon-Keller K et al (2021) Thymus and autoimmunity. Semin Immunopathol 43:45\u201364","journal-title":"Semin Immunopathol"},{"key":"3431_CR34","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1038\/s41467-022-33170-7","volume":"13","author":"Z Xin","year":"2022","unstructured":"Xin Z, Lin M, Hao Z et al (2022) The immune landscape of human thymic epithelial tumors. Nat Commun 13:5463","journal-title":"Nat Commun"},{"key":"3431_CR35","doi-asserted-by":"publisher","first-page":"668696","DOI":"10.3389\/fgene.2022.668696","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Xie L, Li C et al (2022) Prognostic model of eleven genes based on the immune microenvironment in patients with thymoma. Front Genet 13:668696","journal-title":"Front Genet"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03431-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-023-03431-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03431-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T03:21:03Z","timestamp":1689996063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-023-03431-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,15]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3431"],"URL":"https:\/\/doi.org\/10.1007\/s00262-023-03431-5","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,15]]},"assertion":[{"value":"10 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kyoko Itoh has received grants for commissioned and joint research from SCREEN Holdings Co., Ltd., Kyoto, Japan. Hiroshi Ogi and Saya Shibata are employed by SCREEN Holdings Co., Ltd. The remaining authors declare no potential competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of the Kyoto Prefectural University of Medicine (ERB-C-931) and conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written, informed consent was obtained from all patients involved in the present study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study is not publishing any identifiable individual details which would require consent to publish.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}